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Abstract: Cerebral small vessel disease (SVD) is an important cause of stroke, cognitive decline and vascular dementia 
(VaD). It is associated with diffuse white matter abnormalities and small deep cerebral ischemic infarcts. The molecular 
mechanisms involved in the development and progression of SVD are unclear. As hypertension is a major risk factor for 
developing SVD, Spontaneously Hypertensive Rats (SHR) are considered an appropriate experimental model for SVD. 
Prior work suggested an imbalance between the number of blood microvessels and astrocytes at the level of the 
neurovascular unit in 2-month-old SHR, leading to neuronal hypoxia in the brain of 9-month-old animals. To identify 
genes and pathways involved in the development of SVD, we compared the gene expression profile in the cortex of 2 and 
9-month-old of SHR with age-matched normotensive Wistar Kyoto (WKY) rats using microarray-based technology. The 
results revealed significant differences in expression of genes involved in energy and lipid metabolisms, mitochondrial 
functions, oxidative stress and ischemic responses between both groups. These results strongly suggest that SHR suffer 
from chronic hypoxia, and therefore are unable to tolerate ischemia-like conditions, and are more vulnerable to high-
energy needs than WKY. This molecular analysis gives new insights about pathways accounting for the development of 
SVD. 
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INTRODUCTION 
  Cerebral small vessel disease (SVD) is characterized by 
lacunar infarcts and diffuse, ischemic white matter lesions 
(leukoaraiosis) affecting subcortical, periventricular or 
pontine regions, dilated perivascular spaces, and micro-
bleeds. SVD is associated with focal motor deficits, and cog-
nitive decline that often progress to dementia. Hypertension 
has been shown to be an important risk factor for SVD and 
in the development of VaD [1]. The analysis of animal 
models of hypertension in which brain damage is docu-
mented can provide useful information about genes and 
pathways underlying pathophysiological traits in humans. 
Hypertension in SHR impairs cerebrovascular autoregulation 
and CBF responses and aggravates tissue damage after focal 
brain ischemia [2,3]. SHR experience brain atrophy, loss of 
nerve cells in cerebrocortical areas, and glial reaction. Small 
vessels in the cerebral cortex play crucial roles in the 
maintenance of normal tissue blood flow and are the most 
susceptible to vascular dysfunction caused by hypertension. 
The small intraparenchymatous cerebral arteries, including 
resistance arteries, are constitutively exposed to hemody-
namic forces in this rat strain. Consequently, SHR are more 
susceptible to endothelial dysfunction caused by hyperten-
sion and are prone to subsequent SVD such as lacunar 
infarctions, spontaneous intracerebral hemorrhage, and cog- 
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nitive impairment with leukoaraiosis. Cognitive data for 
these animals are spare, however, impaired learning and 
memory were observed coincident with increased anxiety 
[4,5]. 
  Anatomical differences in the brains of SHR were 
already described previously, such as hypertrophy of the 
arterial wall of large arteries [6]. In a previous study, we 
detected cerebral abnormalities at the neurovascular unit 
(NVU) such as enhancement of the number of the capillaries 
and venules and reduction of the number, or atrophy of 
astrocytes in SHR when compared to age-matched normo-
tensive Wistar Kyoto (WKY) controls [7]. The differences 
observed in the densities of capillary and of the astrocytic 
contingent were already significant in young pre-hyper-
tensive, 2-month-old SHR and in stroke-prone SHR (SP-
SHR), as well as in adult 9-month-old animals. This raises 
the question whether factors other than hypertension, such as 
genetic predispositions, induce cellular dysfunction that may 
contribute to the increased susceptibility to brain hypoxia in 
these rat strains. 
  In the NVU, astrocytes are the major intermediary cells 
linking vessels and neurons [8]. They provide neuronal 
nutrition, maintain ionic, neurotransmitter, and metabolic 
homeostasis, and contribute to neuroimmune functions. It is 
not known if a disturbance of the vessel-astrocyte interaction 
causes hypoxia, although it is well described that general 
hypoxia induces the accumulation of hypoxia-inducible 
factor HIF-1 in rat brain tissue [9]. Accumulation of HIF-
1 was observed in neurons of 9-month-old SHR and SP-
SHR, but not in rats aged 2 months, suggesting that the 
cellular imbalance between astrocytes and blood vessels Gene Expression in the Cortex of SHR  Current Neurovascular Research, 2012, Vol. 9, No. 1     11 
reduces exchanges of nutrients and oxygen between blood 
and brain tissue, causing the development of hypoxia-like 
conditions with time.  
  Given the crucial role of astrocytes in maintaining ionic, 
neurotransmitter, and metabolic homeostasis in the brain, we 
need a better molecular understanding of the mechanisms 
inducing this imbalance between microvessels and astrocytes 
observed in the brains of young SHR. 
  Oligonucleotide-based microarray technology is a power-
ful way to gain insight into the molecular pathogenesis of the 
disease. Gene expression profiling may allow identification 
of new players in pathological processes such as small vessel 
disease. This method has been used to detect genes differ-
entially expressed between SHR and WKY, involved in the 
development and maintenance of hypertension in SHR. 
Since renal function have been recognized as a prerequisite 
for the maintenance of all forms of hypertension [10], these 
gene expression analysis have been performed using the 
kidneys as starting material. 
  Using this technology, we examined the differences in 
gene expression profiles in the cortex of young pre-
hypertensive and hypertensive SHR rats versus control 
normotensive WKY. The genes identified with this approach 
may provide guide to potential therapeutic targets for 
neuroprotection to be used in the prevention of small vessel 
disease in patients at risk. 
MATERIAL AND METHODS 
Animals and Brain Tissue Collection 
  The procedures used for the care and euthanasia of the 
animals followed the "Principles of laboratory animal care" 
(NIH publication No. 86-23, revised 1985) and were 
approved by the Animal Welfare Committee Canton Basel 
Land and in compliance with the Swiss Guidelines for the 
Care and Use of Animals. Four (4) spontaneously hyper-
tensive rats (SHR, 2 aged 2 months, 2 aged 9 months) and 4 
Wistar Kyoto rats (WKY, 2 aged 2 months, 2 aged 9 
months) were purchased from Charles River Laboratories 
(Sulzfeld, Germany) and housed in regulated environment 
with free access to food and water. SHR are obtained from 
outbred WKY male with marked elevation of blood pressure 
mated to female with slightly elevated blood pressure. After 
euthanasia (by decapitation following anesthesia with isoflu-
rane), the brains were rapidly removed and immediately 
frozen at -80°C. Brains were mounted in a cryostat and 
coronal sections were made, until the frontal cortex was 
reached (approx. 4 mm anterior to the bregma). Samples 
were then taken using a tissue corer (2 mm diameter, 1 mm 
length) and kept frozen until RNA extraction.  
RNA Preparation and Expression Profiling 
  The frozen brain tissue samples were homogenized in 
Purezol solution (Bio-Rad). Isolation of total RNA from the 
lysate including DNAse I treatment were carried out using 
the BioRad Aurum Total RNA Fatty and Fibrous Tissue kit 
(BioRad) according to the manufacturer’s protocol. The 
purity and quality of the extracted total RNA were 
determined
  using the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA, USA)
  and the NanoChip 
protocol before microarray experiments. Double strand 
cDNA was synthesized from 1  g of total RNA using a 
cDNA Synthesis System (InvitroGen, Basel, Switzerland) 
with the T7-(T)24 primer. The in vitro-labeling kit (Enzo; 
Farmingdale, NY) was used to transcribe the cDNA into 
cRNA in the presence of Biotin-11-CTP and Biotin-16-UTP, 
according to the kit instructions. After purification with the 
MinElute kit (Qiagen; Hilden, Germany), integrity of the 
cRNA were assessed by the BioAnalyzer (Agilent Technolo-
gies, Palo Alto, CA). Twelve (12)  g fragmented cRNA was 
then used for hybridization to the Affymetrix GeneChip
® Rat 
Gene 1.0 ST Arrays (Affymetrix, Santa Clara, CA, USA). 
Sample labeling, hybridization, scanning and data outputs 
were performed according to the manufacturer’s protocols in 
collaboration with the Life Sciences Training Facility, 
Division of Molecular Psychology, University of Basel, 
Switzerland.  
DATA ANALYSIS 
  Microarray data generated from SHR were directly com-
pared to those from WKY, for each age group separately. 
Data expression values were collected as individual CEL 
files for each donor from the Rat Gene 1.0 ST Arrays and 
were then normalized in XRAY (XRay
® statistical program, 
Biotique Systems, Inc., www.biotiquesystems.com) with full 
quantile normalization. The arrays were normalized as a 
single file in XRAY comprised of 8 individual CEL files. 
Data analysis including
 background subtraction, normaliza-
tion, and elimination of false
 positives was performed using 
the default parameters. Mixed model analysis
  of variance 
(ANOVA) was used to identify genes differentially exp-
ressed that exhibited
 significant changes in signal levels with 
a P-value less than 0.05 and fold changes greater than 2.  
  The principal component analysis (PCA) of all samples 
was performed using Partek
® Genomics Suite
TM (Partek GS, 
Partek Inc., St. Louis, MO, USA) to assess variability of the 
data across rat strains and ages.  
Microarray Validation by Quantitative Real-Time PCR 
(qRT-PCR) 
  The microarray results were confirmed by using 
quantitative real-time polymerase chain reaction (qRT-PCR) 
for 3 selected genes that demonstrated significantly altered 
gene expression common between the 2- and 9-month-old 
animals: retinol saturase (Retsat), CD151 antigen, and 
succinate dehydrogenase complex (Sdha). Glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) was used as housekeep-
ing gene. The primers were designed from unique site over 
exon-intron junctions to prevent amplification of genomic 
DNA, and the primers for Gapdh were purchased from 
Qiagen (Hilden, Germany, cat. N° QT00199633). Primer 
sequences were searched against BLAST to ensure that they 
did not match any known gene aside from that for which 
they were designed (especially other family members) and 
are as follows (5’ to 3’): CD151 (Genebank NM_022523): 
CAGTCTGCCTCAAGTATCTG and TGTAGGCTGTTGC 
TAGGTAG; Retinol saturase (Genebank NM_001034126): 
GTGGGAGGAAAGAATACATC and TCAGTAGGATGG 
CATGAGAG; succinate dehydrogenase (Genebank NM_ 
198788): ACAAAGCTCTTTCCTACCCG and TAATGGA 12    Current Neurovascular Research, 2012, Vol. 9, No. 1  Ritz et al. 
TGGCATCCTGATC. First strand cDNA was created from 1 
 g of total RNA using the iScript cDNA synthesis kit from 
Bio-Rad. Quantitative RT-PCR was performed on 1 ng of 
total cDNA per well. Each sample was run in triplicate on 
the Bio-Rad detection system (C1000 and CFX96, Bio-Rad, 
Reinach, Switzerland). Each measurement was made in 
triplicate and expressed relative to the internal control 
GAPDH. The comparative cycle threshold (C(t)) method 
was used to calculate relative quantification of gene expres-
sion. The following formula was used to calculate the rela-
tive amount of the transcripts in the SHR samples and the 
WKY samples, and both were normalized to the endogenous 
control (GAPDH):   C(t)= C(t)SHR- C(t)WKY.  C(t) is 
the difference in C(t) between the target gene and endo-
genous control. The fold-change for the SHR samples 
relative to WKY samples was calculated by 2E-  C(t). 
Statistically significant changes were identified by a two-
tailed t-test with a P-value less than 0.05. 
RESULTS 
Gene Expression Analysis 
  In this study, brain frontal cortical areas from 2 and 9-
month-old SHR and WKY were selected for RNA isolation 
and microarray analysis. Principal Components Analysis 
(PCA) of global gene expression in the 8 rats (4 SHR and 4 
WKY) demonstrated two apparent clusters with the samples 
separating well into SHR and WKY groups (Fig. 1). In each 
group, an additional age-dependent segregation was visible 
(not shown on the figure).  
 
Fig. (1). 3D representation of the principal components analysis 
(PCA) of gene expression profiles in the frontal cortex of SHR and 
WKY. The intensity of the entire gene set was used. Each point in 
the graphic represents a microarray chip and points that are near 
each other denote characteristics that are similar across the entire 
genome. 
  Data filtering identified subsets of genes with significant 
changes in the expression in these 2 rat strains, as sum-
marized in Table 1. In the 2-month-old group a total of 156 
genes were differentially expressed between both rat strains. 
Among these genes, 58 were upregulated and 98 were down-
regulated in SHR compared with WKY. In the 9-month-old 
group, a total of 131 genes were differentially expressed, 
with 69 genes up-regulated and 62 genes down-regulated in 
SHR.  
Table  1.   Number of Significant Differentially Expressed 
Transcripts in the Frontal Cortex of 2- and 9-Month 
Old Spontaneously Hypertensive Rats (SHR) versus 
Age-Matched Normotensive Rats (WKY) (p<0.05, 
Fold Change <-2 or >2) 
 
  2-month-old  9-month-old  Common in both 
Number of genes 
Upregulated 
 
58 
 
69 
 
10 
Downregulated 98  62  7 
Total 156  131  18* 
* one gene was upregulated in 2-month-old SHR but downregulated in 9-month-old 
SHR versus age-matched WKY. 
 
Common Genes Differentially Expressed in both Groups 
of Ages between SHR and WKY 
  Comparing the lists of genes differentially expressed in 2 
and 9-month-old animals, we found 18 common genes. 
Among them, 10 genes were upregulated, and 7 were 
downregulated in SHR compared with WKY. One gene was 
upregulated in the 2-month-old group and downregulated in 
the 9-month-old group (ubiquitine-protein ligase E3).  
These genes differentially expressed could be clustered in 
different cell functions or biological processes as listed in 
Table 2: vascular development and endothelial proliferation, 
CD151, Activin A receptor, p21-activated kinase 2 (Pak2), 
genes that were significantly overexpressed in SHR; mito-
chondrial function and structure: cytochrome c oxidase 
subunit VIIa polypeptide 2 like (Cox7a2l), found overexp-
ressed in SHR, and ribosomal protein L17 (Rpl17), that was 
found underexpressed; energy and lipid metabolisms: suc-
cinate dehydrogenase complex a (Sdha) downregulated, and 
acyl-coenzyme A dehydrogenase (Acadsb) upregulated; oxi-
dative stress responses: retinol saturase (Retsat), nitrilase 
family (Nit), glutathione S-transferase (Gs) both downregu-
lated, Heat shock protein 40 (Hsp40, also called DnaJ), 
upregulated; and protein catabolism: ubiquitin-activating 
enzyme E1 (Ube1), upregulated, and ubiquitin-protein ligase 
E3A (Ube3a) upregulated in 2-month-old SHR but down-
regulated in 9-month-old SHR. Five other genes with 
miscellaneous functions were also found differentially 
expressed between SHR and WKY. 
Quantitative PCR Validation of the Microarray Results 
  To confirm results obtained by Affymetrix arrays, selec-
ted genes from different biological functions in the list of 
differentially expressed genes in common in the 2 and 9-
month-old SHR (Table 2) were analyzed by quantitative RT-
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group. Particular focus on genes involved in each of the 
functional process such as vessel proliferation (CD151 
antigen), energy metabolism (succinate dehydrogenase com-
plex a, Sdha), and oxidative stress (retinol saturase, Retsat) 
were chosen using specific primers. As shown in Fig. (2), 
quantitative RT-PCR confirmed the direction of changes 
seen on the gene microarrays for these genes when com-
paring age-matched SHR with WKY. 
Genes Differentially Expressed Specifically in the 2-
Month-Old Group 
  In addition to the common genes differentially expressed 
in SHR compared with WKY in both ages, we found many 
genes significantly differentially expressed only in 2-month-
old SHR compared with age-matched WKY (Table 3). 
Notably, a cluster of genes for mitochondrial metabolic 
enzymes emerged, comprising beta-oxidation of fatty acids, 
the tricarboxylic acid cycle, and respiratory chain complexes 
phosphorylation, as well as mitochondrial ribosomal pro- 
 
 
Fig. (2). Real-time PCR analysis of selected mRNA found 
differentially expressed between SHR and WKY, common in the 2- 
and 9-month-old groups. Values are mean ± SD (n=4). 
 
Table 2. List of the Differentially Expressed Genes Common in 2- and 9-Month-Old SHR versus Age-Matched WKY 
 
Gene Direction  of  change  P for 2-month-old  P for 9-month-old 
Endothelial proliferation, vascular development      
CD151 antigen  Up in SHR  3.46E-04  2.58E-03 
Activin A receptor  Up in SHR  7.31E-03  1.61E-03 
p21 (CDKN1A)-activated kinase 2  Up in SHR  1.92E-03  5.03E-03 
Mitochondrial function      
Cytochrome c oxidase  Up in SHR  4.39E-02  5.52E-02 
Ribosomal protein L17  Down in SHR  1.73E-02  1.16E-03 
Energy and lipid metabolism      
Succinate dehydrogenase complex a  Down in SHR  8.20E-04  3.44E-02 
Acyl-coenzyme A dehydrogenase  Up in SHR  3.61E-03  9.35E03 
Oxidative stress      
Retinol saturase (all-trans-13)  Down in SHR  3.45E-03  1.54E-03 
Nitrilase family  Down in SHR  1.67E-03  6.77E-04 
Hsp40 (DnaJ)  Up in SHR  8.51E-03  1.05E-03 
Glutathione S-transferase  Down in SHR  1.74E-03  2.76E-03 
Protein catabolism      
Ubiquitin-activating enzyme E1  Up in SHR  1.94E-02  7.85E-04 
Ubiquitin-protein ligase E3  Up in 2-month-old SHR 
Down in 9-month-old SHR 
4.93E-04 
- 
- 
4.67E-03 
Miscellaneous      
Phosphatidylinositol glycan  Up in SHR  9.03E-05  4.20E-04 
Translin-associated factor X  Up in SHR  2.55E-02  1.65E-03 
Neuronal pentraxin receptor  Up in SHR  4.39E-02  3.62E-02 
Secretogranin III  Down in SHR  3.87E-02  3.04E-03 
Eukaryotic translation initiation factor 2C  Down in SHR  8.36E-03  3.14E-03 
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teins. Although the expression of methylmalonyl coenzyme 
A mutase was repressed, the expression of 2 genes belonging 
to oxidative respiration (cytochrome c oxidase, Cox, and 
NADH dehydrogenase Fe-S protein 7, Ndufs7) were higher 
in SHR. Interestingly, the gene for the enzyme glycogen 
phosphorylase, Pygb, was also found overexpressed in the 2-
month-old SHR. There was also an increased expression of 4 
genes involved in anti-oxidant defenses and in the response 
to stress in SHR compared with WKY. In these young 
animals, the expression of a set of 4 genes participating in 
the development and function of the CNS was significantly 
downregulated in SHR. 
Genes Differentially Expressed in the 9-Month-Old 
Group Only 
  In this group, we further found abnormal expression of 
some genes involved in lipid metabolism (carnitine pal-
mitoyltransferase 1c, cpt1c, acetyl-CoA carboxylase , 
Acaca, and glycerol -3 phosphate acyltransferase, Gpam) and 
oxidative phosphorylation (Table 4). In addition, an impor-
tant group of genes inducing protein ubiquitination (ubi-
quitin-activating enzyme E1-domain containing 1, Ube1dc1,  
 
Praja2,  Sumo2) and degradation (dipeptidylpeptidase 10, 
Dpp10) was found mostly overexpressed in older SHR, as 
well as a number of genes involved in cell death (death 
effector domain-containing, Dedd, beclin1, Becn1, macro-
phage migration inhibitor factor, Mif, and colony stimulating 
factor 1 receptor, Csf1r) not found in younger animal. 
Reduced expressions of genes encoding proteins responsible 
for ion homeostasis (ion channels, ATPases), neurotrans-
mitter receptors (glutamate receptor, Grinl1a), synaptic 
signaling (neural stem cell-derived dendrite regulator, 
Dsddr), and other CNS functions were observed in older 
SHR. 
Genes Differentially Expressed Amongst 2- and 9-Month-
Old SHR 
  This analysis comparing gene expression profiles 
between 2 and 9-month-old SHR was aimed to give some 
indication about the genes differentially expressed during 
aging of hypertensive animals. We found 124 genes signifi-
cantly differentially expressed between 2- and 9-month-old 
SHR, 48 being more expressed in 2-month-old SHR and 76 
being more expressed in 9-month-old SHR. A selection of  
 
Table 3. List of the Differentially Expressed Genes in 2-Month-Old SHR versus Age-Matched WKY 
 
Gene Direction  of  change  P value 
Oxidative phosphorylation    
Cytochrome c oxidase subunit VII polypeptide 2  Up in SHR  4.39E-02 
NADH dehydrogenase (ubiquinine) Fe-S protein 7  Up in SHR  1.66E-02 
Mitochondrial ribosomal protein L18  Up in SHR  5.06E-03 
Mitochondrial ribosomal protein L43  Down in SHR  3.15E-03 
Mitochondrial ribosomal protein L48  Down in SHR  3.47E-03 
Methylmalonyl coenzyme A mutase  Down in SHR  3.76E-04 
Demethyl Q7  Up in SHR  1.28E-03 
Carbohydrate and lipid metabolisms    
Brain glycogen phosphorylase  Up in SHR  4.91E-02 
Acyl-coenzyme A dehydrogenase family member 9  Up in SHR  1.16E-03 
Acyl-coenzyme A long-chain family member 3  Down in SHR  3.61E-03 
Carnitine O-octanoyltransferase   Down in SHR  4.23E-03 
Amino acid metabolism    
Branched chain ketoacid dehydrogenase kinase  Up in SHR  4.98E-04 
Cystathionine beta synthase  Up in SHR  2.10E-03 
Anti-oxidant and stress defenses     
Beta-2 microglobulin  Up in SHR  2.21E-03 
Glutathione peroxidase 1  Up in SHR  5.29E-03 
C-terminal binding protein  Up in SHR  5.05E-04 
Lectin  Up in SHR  4.18E-04 
CNS development and function    
Neuropilin and tolloid-like 1  Down in SHR  7.92E-03 
Neuron navigator 3  Down in SHR  9.19E-03 
Somatostatin  Down in SHR  9.66E-03 
Syntaxin 7  Down in SHR  9.01E-03 
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differentially genes is given in Table 5 . Surprisingly, we 
found only one gene, coding for adducin 2-beta, involved in 
the development of hypertension in the brain. This gene was 
overexpressed in 2-month-old SHR. Other genes signifi-
cantly differentially expressed were coding for ion channels, 
involved in nervous system development, all of them 
showing higher expression in 2-month-old SHR. Concerning 
apoptosis, a gene whose expression is thought to inhibit 
apoptosis (PDZ domain containing RING finger 3, Pdzrn3, 
also known as E3 ubiquitin-protein ligase) was more expres-
sed in 2-month-old SHR. In contrast, several genes coding 
for factors inducing apoptosis (SCF apoptosis response 
protein 1, Programmed cell death protein 11, and Septin 4) 
were more expressed in 9-month-old SHR.  
DISCUSSION 
  In the present study, the comparison of gene expression 
in SHR with WKY was performed in order to identify genes 
susceptible to elicit the pathogenesis of SVD. We are aware 
that dividing the groups of rats depending on their age 
limited the sample size (n=2) in each age-driven groups. 
However, the appearance of some identical genes differen- 
tially expressed in both groups of age in the SHR vs. WKY 
 
Table  5.    List of the Differentially Expressed Genes in 2-
Month-Old SHR versus 9-Month-Old SHR 
 
Gene  P value 
More in 2-month-old SHR   
Ion channels  
Calcium channel alpha 1h  4.88E-03 
Voltage-dependent anion channel 1  6.76E-03 
Potassium voltage-gated channel  6.04E-03 
Nervous system development   
Copine IV  7.28E-03 
Neuronal growth regulator 1  3.27E-03 
Development and differentiation enhancer  2.48E-03 
Hypertension-linked genes  
Adducin 2 (beta)  8.42E-03 
Anti-apoptotic genes   
PDZ domain containing RING finger 3  1.80E-03 
More in 9-month-old SHR   
Apoptosis-related genes   
SCF apoptosis response protein 1  1.94E-03 
Programmed cell death protein 11  1.63E-03 
Septin 4  2.34E-03 
 
Table 4. List of the Differentially Expressed Genes in 9-Month-Old SHR versus Age-Matched WKY 
 
Gene Direction  of  change  P value 
Oxidative phosphorylation    
Cytochrome c oxidase subunit IV isoform 1  Up in SHR  5.52E-02 
Carbohydrate and lipid metabolisms    
Carnitine palmitoyltransferase 1c  Up in SHR  3.49E-03 
Acetyl-coenzyme A carboxylase alpha  Down in SHR  9.17E-03 
Glycerol-3-phosphate acyltransferase  Down in SHR  7.03E-03 
Protein catabolism    
Ubiquitin-activating enzyme E1-domain containing1   Up in SHR  7.85E-04 
Praja2  Up in SHR  4.67E-03 
Sumo2  Up in SHR  8.25E-03 
Similar to Cezanne 2 protein  Down in SHR  2.53E-03 
Dipeptidylpeptidase 10  Up in SHR  1.89E-04 
Apoptosis/cell death    
Death effector domain-containing   Up in SHR  2.49E-03 
Beclin 1  Up in SHR  7.17E-04 
Macrophage migration inhibitory factor  Up in SHR  6.41E-03 
Colony stimulating factor 1 receptor  Down in SHR  4.78E-04 
CNS structure and function    
GPI deacetylase  Up in SHR  2.52E-04 
Spectrin beta 3  Down in SHR  6.94E-04 
Calpain 7  Up in SHR  1.45E-03 
Neural stem cell-derived dendrite regulator  Down in SHR  8.33E-03 
Kinesin family member 1A  Down in SHR  3.76E-04 
Kv channel interacting protein 2  Up in SHR  7.26E-03 
K invarding-rectifying channel  Up in SHR  8.65E-03 
Glutamate receptor  Down in SHR  1.93E-03 
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comparisons may strengthen the fact that these genes were 
not emerging by chance. In addition, the comparison of 
young with older SHR that identified genes involved in 
apoptotic pathways indicated that the number of samples is 
still reflecting relevant age effects. Some genes specifically 
expressed in the young (2 months) or the old (9 months) 
animals also appeared. In addition, this grouping also gave 
us some hints about the early deregulations of gene expres-
sion in young pre-hypertensive rats, in which the differences 
may not result from hypertension, but from genetic and/or 
anatomical changes compared to age-matched normotensive 
control animals.  
  The potential relevance of some of the observed mole-
cular differences highlighted in the present study is discussed 
below. 
Vascular Remodeling, Nervous System Development, 
Synaptogenesis 
  Consistent with our previous immunohistological ana-
lysis of the brain of SHR showing capillary proliferation in 
the brain of SHR [7], microarray data indicated that signals 
for angiogenesis are stimulated in the cortex of pre-hyper-
tensive as well as hypertensive SHR. At least 2 genes 
involved in endothelial proliferation were significantly over-
expressed, coding for CD151 antigen and activin A receptor. 
Brain hypoxia is known to induce angiogenic factors such as 
angiopoietin 2 and vascular endothelial growth factor 
(VEGF), thereby complementing the possible adaptation of 
energy metabolism and brain cell membrane ionic homeo-
stasis. An angiogenic adaptive process seems to be switched 
on in SHR, and might be indicative of a chronic status of 
brain hypoperfusion [11].  
  Genes involved in the development of the nervous 
system showed increased expression levels in 2-month-old 
SHR compared to older SHR: Pleiotrophin (PTN), is a 
neurite growth promoting factor for the CNS development 
that can be induced in the adult CNS by ischemic insults 
[12]. Interestingly, this gene is upregulated in macrophages, 
astrocytes and endothelial cells in areas of ischemia-induced 
developing neovasculature. Because PTN is a potent 
angiogenic agent in vitro and in vivo [13], the increase in Ptn 
gene expression may be involved in the higher density of 
small blood vessels observed in the brains of young SHR. 
The expression of neuronal growth regulator 1 (Negr1), a 
cell adhesion protein involved in the trans-neural growth-
promoting factor in regenerative axon sprouting in the 
mammalian brain, was recently found to be upregulated by 
stroke [14]. These relations between increased expression 
during stroke or ischemic condition strongly suggest that 
overexpression of these genes is an indicator of hypoxia in 
the brains of young SHR. 
  Axonal sprouting and changes in the dendritic spines 
have been characterized as potential mechanisms for plasti-
city and self-repair after an ischemic injury to the adult 
brain. Comparing 2-month-old SHR with 9-month-old SHR, 
Copine IV was the gene showing the strongest difference 
with lower expression in 9-month-old animals. This protein 
is specifically expressed in the brain and is involved in 
dendritic development. Post-stroke axonal sprouting remap-
ping the connections of the somatosensory cortex has been 
observed [15], but ischemic preconditioning also promotes 
these processes [16]. Since copines affect spine morphology, 
changes in their expression could contribute or be involved 
in neurodevelopmental disorders. Indeed, deformed dendritic 
spines and dendritic retraction are hallmarks of many neuro-
logical conditions, notably in diseases in which cognitive 
performance is impaired [17]. Dendritic spine loss is repor-
ted in non-Alzheimer’s type dementias, and may represent a 
pathological acceleration of the normal decrease observed in 
senescence. In addition, two genes involved in axonal injury 
were differentially expressed in 9-month-old SHR: Spectrin 
b3 was underexpressed, while Calpain 7 was overexpressed. 
The calpain protein cleaves spectrin, therefore destroying 
cytoskeleton and leading to calpain-mediated axonal demise 
as shown after traumatic brain injury [18]. The reduced 
expression of Copine IV, and Spectrin b3 together with an 
elevated expression of Calpain 7 in 9-month-old SHR may 
participate in the cortical tissue atrophy observed in 
hypertensive animals. 
Mitochondrial Complexes and Energy Production  
  In order to meet a sudden increase in the local energy 
demand, the brain tissue utilizes its stored energy in the form 
of glycogen breakdown as observed by a decrease in the 
glycogen levels in both liver and brain which is accompanied 
by a marked increase in the activity of glycogen phospho-
rylase, PYG. The activity of this cytoplasmic enzyme is 
present mostly in astrocytes [19] and is positively regulated 
by AMP and negatively regulated by ATP, ADP, and 
glucose-6-phosphate. Its overexpression in 2-month-old SHR 
compared to age-matched WKY therefore suggests that brain 
cells in these animals have to mobilize their fuel reserves to 
enhance fluxes in glycolytic and oxidative pathways. 
Overexpression of Pyg may therefore denote an adaptative 
mechanism leading to protect energetically compromised 
neurons in young SHR. 
  Mitochondria have a central function in the energy 
metabolism, and play important roles in generation of free 
radicals, ATP formation, and in apoptosis. Mitochondrial 
dysfunction, understood as the disruption of one or more of 
the events necessary to produce energy, has the immediate 
adverse consequence of energy failure, but also produces a 
massive increase in oxidative stress. Decreased ATP produc-
tion and increased ROS production have been reported in 
various organs such as heart, liver and spleen of SHR [20]. 
In the brain of SHR, previous studies have shown clear signs 
of mitochondrial dysfunctions such as increased Ca
2+ 
accumulation capacity [21], decreased energy production 
[22], and assembly defects in respiratory complexes at the 
protein level [23], that have been proposed to contribute to 
the pathogenesis of hypertension [24]. Proteomic approaches 
have shown that perturbation of a single complex can be 
enough to disrupt the integrity of neighboring complexes 
within the respiratory chain [23]. The present study high-
lights some of the genes that may be involved in these 
defects, such as NADH dehydrogenase Fe-S protein 7 (com-
plex I) and cytochrome c oxidase subunit VII polypeptide 2 
(complex II). These two genes were overexpressed in 2- and 
9-month-old SHR, leading probably to disequilibrium in the 
mitochondrial complexes, or a compensatory phenomenon 
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coding for enzymes of the tricarboxylic acid (TCA) cycle 
occurring in the matrix of mitochondria and responsible for 
the generation of usable energy are also differentially 
expressed in young and old SHR: succinate dehydrogenase 
(Sdha) was found underexpressed in 2- and 9-month-old 
SHR. This mitochondrial enzyme complex participates to 
both the TCA cycle and the respiratory chain: it catalyzes the 
oxidation of succinate to fumarate in the TCA cycle and 
carries electrons to the ubiquinone pool of the respiratory 
chain. Deficiency of SDHA has been shown to be associated 
with a specific leukoencephalopathic syndrome [25,26]. 
Moreover, the heme group of this enzyme prevents the 
production of reactive oxygen species, therefore reducing 
oxidative stress. A reduced expression in SHR may therefore 
have severe consequences in terms of energy production and 
cellular stress. 
Lipid Metabolism 
  As in human with monogenic disorders of blood pressure 
regulation, SHR show hypertension-associated metabolic 
lipid and glucose disturbances [27]. However, changes in 
expression of genes involved in the incorporation of fatty 
acids have also been observed in young, pre-hypertensive 
SHR, and particularly a decreased expression of a gene 
responsible for the synthesis of long-chain fatty acyl-CoAs 
(Acyl-CoA long-chain family member 3, Acsl3), suggesting 
that these differences in gene expression are hypertension-
independent. Young and older SHR also showed increased 
expression of the gene coding for the fat metabolizing 
enzyme acyl-CoA dehydrogenase family (Acad9) acting 
during the first step of mitochondrial beta oxidation of fatty 
acids vital for energy production in periods of fasting and 
other metabolic stress. Young SHR showed decreases in the 
expression of long-chain acyl CoA member 3 (Acsl3) and 
carnitine O-octanoyltransferase genes. An underexpression 
of methylmalonyl Coenzyme A mutase (Mcm) has also been 
observed in 2-month-old SHR. This enzyme generates suc-
cinyl-CoA, a key molecule of the TCA cycle. Older SHR 
showed decreased expression in glycerol 3-phosphate acyl-
transferase (Gpa), and acetyl CoA carboxylase alpha (Acca), 
whose products provide substrates for the biosynthesis of 
fatty acids, and an increase in the expression of carnitine 
palmitoyltransferase 1c (Gpt1c), essential for the transport of 
fatty acids into the mitochondria. These changes in gene 
expression therefore indicate that cellular energy stored in 
body fat might be low in these animals. It may also partly 
explain the reduced body weight of SHR compared with 
WKY observed in our previous study, due to reduced 
adipose tissue mass [7].  
Oxidative Stress Response 
  Four genes involved in stress resistance and detoxi-
fication have been found differentially expressed in young 
and old SHR. Retinol saturase (Retsat) as well as nitrilase 
family (Nit) and glutathione S-transferase (Gst) were under-
expressed in SHR. This decrease may therefore adversely 
affect detoxification and allow oxidative damage to spread. 
Hsp40 implicated in various cellular functions, such as 
proper protein folding, protein transport, and response to 
stress was overexpressed in SHR. In contrast, in young SHR 
specifically, additional genes were found overexpressed: 
Glutathione peroxidase 1 (Gp1), known to protect organism 
form oxidative damage, and C-terminal binding protein 
(Ctbp), acting as a metabolic stress sensor [28], suggesting 
that there is an attempt to overcome the increased oxidative 
stress in young SHR. Beta-2 microglobuline and lectin 
overrepresentation, in addition to their roles in inflammation 
and intracellular traffic, respectively, is also associated with 
cellular stress in the brain. 
Response/Susceptibility to Ischemia  
  In order to identify the contributors of the development 
of diffuse ischemic white matter lesions and lacunar infarcts 
characteristic of vascular dementia, a number of genes invol-
ved in the resistance and /or response to ischemia represent 
probably the best candidates. Glutathione S-transferase (Gst) 
detoxifies reactive oxygen species produced during brain 
ischemia. Decreased expression of Gst has been observed in 
SHR after stroke [29], as well as in the present study. It also 
suggests that brains of young and aged SHR suffer from 
chronic ischemia. Colony-stimulating factor-1 receptor (Csf-
1r) that is weakly expressed by neurons in most area of the 
brain is upregulated in the area next to the ischemic lesion 
after ischemic injury [30]. CSF-1R is then expressed by 
neurons and microglia, and interacts with CSF produced by 
astrocytes, promoting neuronal survival. The CSF/CSF-1R 
signaling is therefore an important pathway between neu-
rons, microglia and astrocytes. A defective expression of 
CSF or CSF-1R in the brain makes it considerably more 
vulnerable to ischemia [31]. The significant deficit in Csf-1r 
expression in 9-month-old SHR may therefore indicate a 
higher susceptibility of the tissue to hypoxia/ ischemia in 
these animals. Aggravation of neurological deficits by 
macrophage migration inhibitory factor (MIF) has been 
shown after experimental stroke and increases in MIF has 
been observed in cultured cortical neurons exposed to 
oxygen and glucose deprivation [32]. Therefore, the 
increased expression of Mif noted in 9-month-old SHR may 
point toward a low energy status in the brain tissue. 
  Furthermore, adenylate cyclase activating polypeptide 1 
(Acap1) was overexpressed in 2-month-old animals. It is 
induced by chronic stress and may underlie the maladaptive 
remodeling and plasticity of brain regions associated with 
anxiety-like behavior [33]. 
Hypertension Involved Genes 
  A number of genes differing in their expression level in 
SHR and supposed to confer hypertension have been charac-
terized in kidneys [34,35]. However, except glutathione S-
transferase (Gst), none of the revealed genes involved in the 
development of hypertension were found to be common in 
both analyses. Recently, evidence of the implication of only 
one renal gene (Cd36) predisposing to hypertension in SHR 
was clearly demonstrated [36]. Our comparison between the 
2 and 9-month-old SHR may highlight additional genes 
involved in the development of hypertension, such as 
adducin-2b expressed more in 2-month-old than in 9-month-
old SHR. Adducin-2b, Add2, was the unique gene showing 
changes in expression between 2- and 9-month-old SHR. A 
direct role of this protein in modulating arterial blood pres-
sure was demonstrated using a adducin-2b-deficient mouse 
strain [37]. Indeed, the deficiency in adducin-2b induced 18    Current Neurovascular Research, 2012, Vol. 9, No. 1  Ritz et al. 
hypertension, suggesting that in 9-month-old SHR, the 
decrease in gene expression may lead to an increase of blood 
pressure.  
Apoptosis 
  As leukoaraiosis is an age-dependent degenerative 
condition caused by chronic ischemia, apoptosis in the white 
matter adjacent to leukoaraiosis lesions have already been 
demonstrated [38]. Several genes involved in the activation 
of apoptotic cell death have appeared differentially expressed 
in 9-month-old SHR only, but not in the younger 2-month-
old animals. Two genes inducing cell death were found 
overexpressed in the oldest SHR: beclin1 (Becn1, and death 
effector domain-containing (Dedd). Mif can also be grouped 
in this class of genes, since the upregulation of MIF after 
experimental stroke was shown to promote cell death [32]. 
One gene exhibiting an anti-apoptotic action (ubiquitin-
protein ligase E3) was found underexpressed in aged SHR 
compared to the younger SHR and to the age-matched 
WKY, clearly indicating a condition stimulating prog-
rammed cell death in the brain of hypertensive SHR.  
  This study strongly suggests that young - yet pre-hyper-
tensive - SHR suffer from chronic hypoxia-like conditions. 
The majority of genes that were expressed differently in 
SHR compared with age-matched WKY are known to 
respond to ischemia by altered expression. Several genes 
coding for mitochondrial complexes and functions, and for 
detoxifying and survival factors are also unsuitably exp-
ressed, rendering SHR more susceptible to ischemic injury 
and more vulnerable to high-energy consumption conditions. 
This molecular analysis therefore provides valuable new 
insights into the pathways accounting for the development of 
SVD. If these observations can be reproduced in human 
SVD, these findings might offer targets for preventive ther-
apeutic options. Treatments aimed to improving brain energy 
metabolism and alleviating oxidative stress are definitely 
good candidates for this purpose. 
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